RCRenata Di Pietro Carvalho

Renata Di Pietro Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Renata Di Pietro Carvalho has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vigilância Epidemiológica da coqueluche em Minas Gerais: tendências temporais e padrões espaciais (2014–2024)

    by Claúdio Luiz Ferreira Júnior, Wadson Souza da Silva, Renata Di Pietro Carvalho, Carolina Di Pietro Carvalho, Kesley Duarte de Jesus, Mariana Cristina Rocha Nunes, Cleya da Silva Santana Cruz

    A coqueluche é uma infecção aguda de transmissão respiratória e presente em todo o mundo, pode ser prevenida por imunização e representa um risco significativo para a saúde infantil. O presente estudo teve como objetivo analisar a distribuição espaço-temporal de coqueluche em Minas Gerais entre 2014 e 2024, identificando áreas de maior risco e a dinâmica temporal da doença. Estudo ecológico de base populacional utilizando dados secundários do Portal de Vigilância em Saúde de Minas Gerais. Foram aplicados Modelos Aditivos Generalizados (GAM) e estatística Scan para detecção de aglomerados espaço-temporais. Em Minas Gerais foram confirmados 2.161 casos de coqueluche, com incidência média de 1,95/100.000 habitantes, destacando-se maiores incidências nas macrorregiões Centro (6,47/100.000), Sul (3,86/100.000) e Triângulo do Norte (2,42/100.000). A análise gráfica utilizando GAM revelou queda no risco entre 2015 e 2021, seguida de ascensão a partir de 2022. Foram identificados clusters de alto risco em diferentes momentos, sobretudo em 2024, envolvendo macrorregiões Norte, Noroeste, Jequitinhonha, Centro, Oeste, Sul, Sudoeste, Centro-Sul. O estudo identificou padrão cíclico e heterogêneo da coqueluche em Minas Gerais, com recrudescimento após 2022 e clusters de alto risco em regiões vulneráveis. Os achados reforçam a necessidade de vigilância contínua e georreferenciada, com foco em áreas socioeconomicamente vulneráveis, a fim de prevenir a reemergência da doença e subsidiar políticas públicas eficazes.

  • Open Access

    Epidemiological Surveillance of pertussis in Minas Gerais: temporal trends and spatial patterns (2014–2024)

    by Claúdio Luiz Ferreira Júnior, Wadson Souza da Silva, Renata Di Pietro Carvalho, Carolina Di Pietro Carvalho, Kesley Duarte de Jesus, Mariana Cristina Rocha Nunes, Cleya da Silva Santana Cruz

    Pertussis is an acute respiratory infection with worldwide distribution that can be prevented through immunization and represents a significant risk to child health. This study aimed to analyze the spatiotemporal distribution of pertussis in Minas Gerais between 2014 and 2024, identifying high-risk areas and the temporal dynamics of the disease. This was a population-based ecological study using secondary data from the Minas Gerais Health Surveillance Portal. Generalized Additive Models (GAM) and spatial scan statistics were applied to detect spatiotemporal clusters. In Minas Gerais, 2,161 cases of pertussis were confirmed, with an average incidence of 1.95 per 100,000 inhabitants. The highest incidences were observed in the Central (6.47/100,000), Southern (3.86/100,000), and Northern Triângulo (2.42/100,000) macro-regions. The GAM-based graphical analysis revealed a decline in risk between 2015 and 2021, followed by a resurgence beginning in 2022. High-risk clusters were identified at different time points, particularly in 2024, involving the Northern, Northwestern, Jequitinhonha, Central, Western, Southern, Southwestern, and Central-Southern macro-regions. The study identified a cyclical and heterogeneous pattern of pertussis in Minas Gerais, with recrudescence after 2022 and high-risk clusters in vulnerable regions. These findings reinforce the need for continuous and georeferenced surveillance, with a focus on socioeconomically vulnerable areas, to prevent disease reemergence and support effective public health policies.

  • Open Access

    “It’s not all about the disease”: do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis?

    by Carolina Di Pietro Carvalho, João Gabriel Guimarães Luz, Amanda Gabriela de Carvalho, Renata Di Pietro Carvalho, Herton Helder Rocha Pires, João Victor Leite Dias

    This cross-sectional study compared the general impact of cutaneous leishmaniasis (CL) and patient satisfaction with treatment and health services as perceived by those undergoing different therapeutic regimens in an endemic region in South-Eastern Brazil. We also investigated the factors associated with both outcomes (general impact and satisfaction). We included 84 patients with CL treated between 2018 and 2019 with intravenous meglumine antimoniate, liposomal amphotericin B, or intralesional meglumine antimoniate therapy. Data were collected through interviews that assessed sociodemographic characteristics, comorbidity status, access and use of health services for CL diagnosis and treatment, and the items of the Cutaneous Leishmaniasis Impact Questionnaire (CLIQ). The CLIQ is a psychometric questionnaire previously validated to assess the general impact of CL on patient satisfaction with treatment and health services. Multivariate logistic regression analysis was used to identify the factors associated with high CL impact and low patient satisfaction. The general impact of CL and patient satisfaction with treatment and health services were not significantly associated with the therapeutic regimen. High CL impact was associated with low family income (odds ratio [OR]:3.3; 95% confidence interval [CI]:1.0-10.3), occurrence of complications/adverse effects during treatment (OR:7.7; 95%CI:2.4-25.6), and additional costs during diagnosis and/or treatment (OR:12.1; 95% CI:2.8-52.4). Low satisfaction was associated with high disease impact (OR: 9.5; 95% CI:2.7-33.9), occurrence of complications/adverse effects (OR:4.2; 95% CI:1.3-13.0), and high family income (OR:7.1; 95%CI:1.7-28.2). Our data support public health policies aimed at reducing the impact of CL and its treatment as well as the use of therapy with fewer adverse effects.